Infectious diseases are becoming increasingly more difficult to manage. 

Molecular biology tools bring a high level of sensitivity and specificity to diagnostics. These tools can detect bacteria, viruses, parasites, yeasts, or genetic markers through the presence of DNA or RNA genetic sequences in clinical samples. Tests are performed directly on a clinical sample and make it possible to obtain results in as little as ~15 minutes.

In addition to detecting pathogens, molecular tests can identify antimicrobial genes and can allow for viral quantification in patient's samples. These results help clinicians make decisions regarding treatment and monitor the effectiveness of treatment.

Molecular diagnostics have revolutionized the field of medical testing by allowing for earlier and more accurate diagnosis, personalized treatment plans, and improved patient outcomes. 

These tests are being used more and more to guide patient management.  From diagnosis to treatment, particularly in infectious diseases, clinicians need molecular tools that are reliable, fast, and easy to use.

Healthcare professionals often experience slow, incomplete, and unreliable tests to identify pathogens of infectious diseases and accompanying antimicrobial resistance genes, resulting in suboptimal patient treatment and management. 

The accessibility to a complete diagnosis, especially on molecular assays, has never been so easy but infectious disease labs still have high expectations:

• Same-day Results: expectation for fast turnaround times; testing is expected to be completed the same day specimen is received
  
• Flexibility: ability to manage a variety of different samples and manage different contexts: routine testing, research topics, clinical trials, and more
  
• Accuracy: reduce the incidence of under-quantification, false negative or positive results
  
• Safety Concerns: minimize all cross-contamination risk especially during the pipetting steps and ensure operator safety

It’s imperative that labs have the products and solutions that guarantee the highest levels of reliability, rapidity, and safety. Molecular technologies offer an effective solution for infectious disease diagnostics because they are agile, fast, reliable, and precise.

Molecular diagnostic solutions from bioMérieux play a crucial role in identifying and detecting various infectious diseases. Our offer includes flexible molecular systems and integrated multiplex PCR systems with a broad menu of high-quality in vitro diagnostics, plus expert support. We help healthcare professionals quickly and accurately diagnose infections, monitor disease progression, and guide appropriate treatment decisions. Our goal is to not only help labs succeed in addressing current and future disease management, but also enable the scalability to react in an outbreak situation.

Our solutions confidently meet the challenges faced by labs by offering same-day reliable results with flexible workflows and systems designed to reduce safety risk. The routine use of our molecular diagnostic solutions will help decrease healthcare resources, increase efficiency, and allow rapid responses to new threats.

Testing early with molecular diagnostic solutions from bioMérieux has demonstrated improved patient outcomes, optimized patient management, better antimicrobial stewardship, and cumulative cost and time-savings realized throughout the entire patient pathway.